Format

Send to

Choose Destination
Protein Cell. 2019 Feb;10(2):137-142. doi: 10.1007/s13238-018-0604-x.

Structure-activity relationship optimization for lassa virus fusion inhibitors targeting the transmembrane domain of GP2.

Zhang G1,2,3,4, Cao J1,5, Cai Y2,3,4, Liu Y1, Li Y2,3,4, Wang P1,5, Guo J1,5, Jia X1,5, Zhang M1,2,3,4, Xiao G1,5, Guo Y2,3,4, Wang W6,7.

Author information

1
State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China.
2
College of Pharmacy and State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, 300450, China.
3
Drug Discovery Center for Infectious Disease, Nankai University, Tianjin, 300071, China.
4
Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, 300450, China.
5
University of the Chinese Academy of Sciences, Beijing, 100049, China.
6
State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China. wangwei@wh.iov.cn.
7
University of the Chinese Academy of Sciences, Beijing, 100049, China. wangwei@wh.iov.cn.

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center